Sintilimab plus GemOx is an effective salvage therapy in patients with refractory/relapsing nodal peripheral T cell lymphomas
Authors
- Hua‐Wei Jiang (ORCID: https://orcid.org/0000-0001-8970-3770)
- Huyi Lei
- Mengmeng Hu (ORCID: https://orcid.org/0000-0002-9625-0295)
- Panpan Chen (ORCID: https://orcid.org/0000-0002-6992-7248)
- Xibin Xiao (ORCID: https://orcid.org/0000-0002-9941-446X)
Institutions
- Second Affiliated Hospital of Zhejiang University (CN)
- Shaoxing People's Hospital (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1007/s00432-024-05956-3
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42